AF647 Anti-Human CD19 Antibody[4G7]

The AF647 Anti-Human CD19 Antibody [4G7] is a highly specific and reliable tool designed for the detection and analysis of CD19 expression in human samples. This monoclonal antibody, produced through advanced biotechnological methods, exhibits exceptional affinity and selectivity towards the CD19 antigen, making it an ideal choice for various research applications.

The CD19 antigen is a transmembrane glycoprotein expressed on the surface of B cells, making it a valuable marker for the identification and characterization of B cell populations. The AF647 Anti-Human CD19 Antibody [4G7] binds to CD19 with high precision, enabling accurate and efficient detection of CD19-positive cells in flow cytometry, immunohistochemistry, and other immunological techniques.

With its AF647 fluorochrome conjugation, this antibody offers enhanced sensitivity and signal intensity, facilitating the detection of low-abundance CD19-expressing cells. Its exceptional performance ensures reliable and reproducible results, enabling researchers to obtain valuable insights into B cell biology, immune responses, and disease mechanisms.

The AF647 Anti-Human CD19 Antibody [4G7] is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody conjugation procedures. Its formulation ensures long-term stability and consistent performance, allowing for convenient and hassle-free experimental setup.

This antibody is manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reliability. It is extensively validated for its specificity, sensitivity, and functionality, guaranteeing optimal performance in a wide range of experimental conditions.

In summary, the AF647 Anti-Human CD19 Antibody [4G7] is a highly specific, reliable, and convenient tool for the detection and analysis of CD19 expression in human samples. Its exceptional performance and ease of use make it an invaluable asset for researchers in the fields of immunology, oncology, and biomedical research.